Skip to content

Total Intravenous Anesthesia (TIVA) Versus Inhalational Anesthesia at The End of Laparoscopic Obstetric Surgery Regarding Postoperative Nausea and Vomiting

Total Intravenous Anesthesia (TIVA) Versus Inhalational Anesthesia at The End of Laparoscopic Obstetric Surgery Regarding Postoperative Nausea and Vomiting

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07270289
Enrollment
98
Registered
2025-12-08
Start date
2025-12-31
Completion date
2027-12-31
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Obstetric Surgery

Brief summary

Postoperative nausea and vomiting (PONV) remain among the most common and distressing complications after general anaesthesia, with important consequences for patient comfort, satisfaction, recovery trajectories, and length of stay following surgery. The incidence of PONV is especially high after laparoscopic and gynaecological procedures due to patient- and procedure-related risk factors, making effective prevention and management a priority in perioperative care \[5,8\]. Anaesthetic technique is a recognized, modifiable determinant of PONV. Numerous clinical trials and randomized studies have demonstrated that the choice between propofol-based total intravenous anaesthesia (TIVA) and volatile inhalational maintenance can materially influence PONV incidence. Propofol-based TIVA has been repeatedly associated with lower rates of early and overall PONV compared with volatile agents in diverse surgical populations, supporting its role as an antiemetic strategy in addition to pharmacologic prophylaxis \[1,2,4,9\]. Trials specifically conducted in gynaecological and laparoscopic surgical populations report consistent reductions in nausea and vomiting with propofol maintenance compared with isoflurane or other volatile agents. These procedure-specific data are directly relevant to studies in gynecological laparoscopy, where baseline PONV risk is elevated and where anesthetic technique may yield a clinically meaningful reduction in patient morbidity \[5,8,9\]. Meta-analyses and systematic reviews pooling randomized controlled trials provide higher-level evidence that TIVA reduces the relative risk of PONV compared with volatile anaesthesia. Trial-sequential and pooled analyses estimate a clinically important risk reduction favoring TIVA, although effect sizes vary with study populations, prophylactic antiemetic regimens, and outcome time windows; these syntheses underpin the rationale for a targeted randomized comparison in the gynecological laparoscopic setting \[2,4,10\].

Interventions

PROCEDUREinhalational anaesthesia

patients will be offed from inhalational anesthesia

patients will be Switched Total Intravenous Anesthesia (TIVA)

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Female, age 18-50 years. * Elective laparoscopic procedure under general anaesthesia with endotracheal intubation. * Expected surgical duration ≥ 30 minutes. -.Ability to consent and complete questionnaires

Exclusion criteria

* Pregnancy or lactation. * BMI ≥ 40 kg/m²; severe cardiopulmonary disease; hepatic/renal failure. * History of malignant hyperthermia or contraindication to study drugs. * Known allergy to propofol, , , sevoflurane/desflurane.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of post operative neasea24 hoursAny episode of nausea (NRS ≥ 4/10 or requiring treatment)
incidance of postoperative vomting24 hoursany episode of vomiting/retching recorded at 0-2, 2-6, and 6-24 h; need for rescue antiemetic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026